InsidersTradesSigma
Track the Atrium Therapeutics, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Market capitalisation: €212.5m. The latest transaction was disclosed on 22 April 2026 (Attribution). Among the most active insiders: Younis Husam. All data is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
Atrium Therapeutics, Inc. is a company focused on developing innovative treatments for cardiovascular diseases. It is listed on the NASDAQ under the ticker symbol ATRM.